GNMX
Aevi Genomic Medicine Inc
GNMX
GNMX
Delisted
GNMX was delisted on the 3rd of February, 2020.
49 hedge funds and large institutions have $12.6M invested in Aevi Genomic Medicine Inc in 2017 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 14 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Holders
49
Holding in Top 10
–
Calls
–
Puts
$1K
Top Buyers
| 1 | +$3.69M | |
| 2 | +$134K | |
| 3 | +$74K | |
| 4 |
NCMW
Northern Capital Management (Wisconsin)
Madison,
Wisconsin
|
+$58.3K |
| 5 |
VF
Virtu Financial
New York
|
+$45K |
Top Sellers
| 1 | -$383K | |
| 2 | -$165K | |
| 3 | -$149K | |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$131K |
| 5 |
Morgan Stanley
New York
|
-$62.5K |